[1] Sheng L, Cao WK. HIV/AIDS epidemiology and prevention in China. Chin Med J (Engl), 2008; 121, 1230−6. doi:  10.1097/00029330-200807010-00016
[2] Des Jarlais DC, Johnston P, Friedmann P, et al. Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China. BMC Public Health, 2005; 5, 89. doi:  10.1186/1471-2458-5-89
[3] Peng ZH, Cheng YJ, Reilly KH, et al. Spatial distribution of HIV/AIDS in Yunnan province, People's Republic of China. Geospat Health, 2011; 5, 177−82. doi:  10.4081/gh.2011.169
[4] Ma SZ, Chen Y, Lai XL, et al. Predicting the HIV/AIDS epidemic and measuring the effect of AIDS Conquering Project in Guangxi Zhuang Autonomous Region. PLoS One, 2022; 17, e0270525. doi:  10.1371/journal.pone.0270525
[5] Chen HH, Luo LH, Pan SW, et al. HIV epidemiology and prevention in southwestern China: trends from 1996-2017. Curr HIV Res, 2019; 17, 85−93. doi:  10.2174/1570162X17666190703163838
[6] He X, Xing H, Ruan YH, et al. A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey. PLoS One, 2012; 7, e47289. doi:  10.1371/journal.pone.0047289
[7] Tang HL, Cai C, Cui Y, et al. Epidemiological characteristics of newly diagnosed cases of HIV through injection drug use - China, 2012-2019. China CDC Wkly, 2020; 2, 920−3. doi:  10.46234/ccdcw2020.251
[8] Zhang B, Yan XY, Li YJ, et al. Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study. Harm Reduct J, 2021; 18, 63. doi:  10.1186/s12954-021-00511-6
[9] Hemelaar J, Gouws E, Ghys PD, et al. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS, 2011; 25, 679−89. doi:  10.1097/QAD.0b013e328342ff93
[10] Chen M, Ma YL, Chen HC, et al. Spatial clusters of HIV-1 genotypes in a recently infected population in Yunnan, China. BMC Infect Dis, 2019; 19, 669. doi:  10.1186/s12879-019-4276-9
[11] Li K, Liu ML, Chen HH, et al. Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China. Emerg Microbes Infect, 2021; 10, 497−506. doi:  10.1080/22221751.2021.1899056
[12] Feng Y, Takebe Y, Wei HM, et al. Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC. Sci Rep, 2016; 6, 19279. doi:  10.1038/srep19279
[13] Ge ZW, Feng Y, Zhang H, et al. HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance. Emerg Microbes Infect, 2021; 10, 1919−30. doi:  10.1080/22221751.2021.1978822
[14] Nikolopoulos GK, Kostaki EG, Paraskevis D. Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. Infect Genet Evol, 2016; 46, 256−68. doi:  10.1016/j.meegid.2016.06.017
[15] Fan Q, Zhang JF, Luo MY, et al. Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed eastern China, 2017-2020. Emerg Microbes Infect, 2022; 11, 2326−39. doi:  10.1080/22221751.2022.2119167
[16] Liao HN, Tee KK, Hase S, et al. Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. Virology, 2009; 391, 51−6. doi:  10.1016/j.virol.2009.05.023
[17] Wang XL, He X, Zhong P, et al. Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China. Sci Rep, 2017; 7, 6330. doi:  10.1038/s41598-017-06573-6
[18] Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol, 2000; 74, 11286−95. doi:  10.1128/JVI.74.23.11286-11295.2000
[19] Su L, Graf M, Zhang YZ, et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol, 2000; 74, 11367−76. doi:  10.1128/JVI.74.23.11367-11376.2000
[20] Kato K, Kusagawa S, Motomura K, et al. Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam-China border. AIDS Res Hum Retroviruses, 2001; 17, 113−23. doi:  10.1089/08892220150217201
[21] Jiang Y, Zhang LC, Hou ZJ, et al. Prevalence of different genotypes of HIV-1 in injection drug users in China: a systematic review and meta-analysis. Curr HIV Res, 2019; 17, 240−57. doi:  10.2174/1570162X17666190919115036
[22] Su L, Feng Y, Liang S, et al. The origin and spread of CRF85_BC, driven by heterosexual transmission among older people in Sichuan, China. BMC Infect Dis, 2020; 20, 772. doi:  10.1186/s12879-020-05488-4
[23] Li JJ, Feng Y, Shen ZY, et al. HIV-1 transmissions among recently infected individuals in southwest china are predominantly derived from circulating local strains. Sci Rep, 2018; 8, 12831. doi:  10.1038/s41598-018-29201-3
[24] Wang XF, Liu XS, Li F, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015. PLoS One, 2018; 13, e0198005. doi:  10.1371/journal.pone.0198005
[25] Pang XW, Wei H, Huang JH, et al. Patterns and risk of HIV-1 transmission network among men who have sex with men in Guangxi, China. Sci Rep, 2021; 11, 513. doi:  10.1038/s41598-020-79951-2
[26] Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol, 2007; 7, 214. doi:  10.1186/1471-2148-7-214
[27] Gill MS, Lemey P, Faria NR, et al. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol, 2013; 30, 713−24. doi:  10.1093/molbev/mss265
[28] Drummond AJ, Ho SY, Phillips MJ, et al. Relaxed phylogenetics and dating with confidence. PLoS Biol, 2006; 4, e88. doi:  10.1371/journal.pbio.0040088
[29] Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS, 2000; 14, 75−83. doi:  10.1097/00002030-200001070-00009
[30] Yang RG, Kusagawa S, Zhang CY, et al. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol, 2003; 77, 685−95. doi:  10.1128/JVI.77.1.685-695.2003
[31] Bao YP, Liu ZM, Lu L. Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry, 2010; 23, 187−94. doi:  10.1097/YCO.0b013e328338658b
[32] Feng Y, He X, Hsi JH, et al. The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s. AIDS, 2013; 27, 1793−802. doi:  10.1097/QAD.0b013e328360db2d
[33] Zhang J, Shen ZY, Li Z, et al. Genetic characteristics of CRF01_AE among newly diagnosed HIV-1-infected 16- to 25-year olds in 3 geographic regions of Guangxi, China. Medicine (Baltimore), 2015; 94, e894. doi:  10.1097/MD.0000000000000894
[34] Chen Y, Shen ZY, Feng Y, et al. HIV-1 subtype diversity and transmission strain source among men who have sex with men in Guangxi, China. Sci Rep, 2021; 11, 8319. doi:  10.1038/s41598-021-87745-3
[35] Baeten JM, Chohan B, Lavreys L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis, 2007; 195, 1177−80. doi:  10.1086/512682
[36] Stephenson KE, Barouch DH. A global approach to HIV-1 vaccine development. Immunol Rev, 2013; 254, 295−304. doi:  10.1111/imr.12073
[37] Hué S, Pillay D, Clewley JP, et al. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci USA, 2005; 102, 4425−9. doi:  10.1073/pnas.0407534102
[38] Gan MZ, Zheng S, Hao JJ, et al. The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China. Emerg Microbes Infect, 2021; 10, 256−65. doi:  10.1080/22221751.2021.1884004
[39] Alirol E, Getaz L, Stoll B, et al. Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis, 2011; 11, 131−41. doi:  10.1016/S1473-3099(10)70223-1
[40] Hammett TM, Des Jarlais DC, Kling R, et al. Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China. PLoS One, 2012; 7, e43141. doi:  10.1371/journal.pone.0043141
[41] Shao YM, Jia ZW. Challenges and opportunities for HIV/AIDS control in China. Lancet, 2012; 379, 804.
[42] Region TPsGoGZA. Implementation plan of Guangxi AIDS conquering project (2010-2014). 2010.